MELRILIMAB
UNII 26C72EGQ3G

Substance Identification & Data

This profile provides standardized clinical and technical data for Melrilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 26C72EGQ3G.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2222865-46-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

26C72EGQ3G

CAS Registry Number

2222865-46-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MELRILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175124

National Cancer Institute reference terminology for clinical and research data.

INN ID

11351

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-25

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Melrilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MELRILIMAB

Common Names & Synonyms

HUMAN IGG2 SIGMA KAPPA ANTI-IL-33 MONOCLONAL ANTIBODY GSK3772847

IMMUNOGLOBULIN IGG2, ANTI-(HUMAN INTERLEUKIN 1 RECEPTOR-LIKE 1 PROTEIN) (HUMAN MONOCLONAL GSK3772847 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GSK3772847 .KAPPA.-CHAIN, DIMER

MELRILIMAB [INN]

MELRILIMAB [USAN]